A message from Dr. Jan Friedman, Acting Executive Director, CFR
While Dr. Hammond’s departure is a loss for CFRI, I am pleased to announce we will continue to benefit from strong scientific leadership through the appointment of Dr. Catherine Pallen as Acting Deputy Director starting February 1, 2012.
I would like to thank both Dr. Hammond and Dr. Pallen in advance for their efforts over the next month to ensure a smooth and seamless leadership transition for CFRI.
In the coming months, we will formally recognize Dr. Hammond for his contributions and achievements during his tenure with CFRI. In the meantime, I would like to acknowledge his instrumental role in guiding CFRI through years of tremendous growth that included the institute’s redirection, construction of the Translational Research Building and recruiting new scientific talent—both established investigators and young scientists—to CFRI. Dr. Hammond has led a number of CFRI initiatives to build capacity, improve strategic supports, and promote excellence in research and training. He has overseen the development and maturation of three essential core services of CFRI: the Research & Technology Development Office, Information Technology Services, and Facilities and Operations, including optimizing core research facilities and services.
Recognized internationally as an expert in the area of steroid hormone action, Dr. Hammond holds a Tier 1 Canada Research Chair in Reproductive Health. He has published more than 200 scientific articles and reviews, and has served on numerous editorial boards and organizing committees of international meetings. Dr. Hammond will retain his position as Professor in the UBC Department of Obstetrics and Gynaecology and plans to relocate his lab to UBC’s Life Sciences Institute on the Point Grey campus later this year.
Dr. Pallen is a scientist and Associate Director of CFRI’s Childhood Cancer & Blood Research cluster. She is Professor, Division of Hematology and Oncology, UBC Department of Pediatrics, and Associate Member, UBC Department of Pathology and Laboratory Medicine. Since moving to CFRI in 2001 from the Institute of Molecular and Cell Biology in Singapore, Dr. Pallen has contributed to the CFRI and UBC research communities by participating on several committees aimed at celebrating and recognizing research excellence, enhancing the training environment, improving workplace safety, and developing research facilities. She has also served UBC through the Department of Pediatrics Promotion and Tenure Committee and a number of search committees. On the national level, Dr. Pallen has been a member of the Canadian Institutes of Health Research review panels for Molecular Cell Cancer and Cell Physiology. Dr. Pallen holds a PhD in Medical Biochemistry from the University of Calgary and is highly regarded for her research on cell signaling by protein tyrosine phosphatases.
To contact Dr. Pallen, please email her at email@example.com.
Please join me in congratulating and wishing every success to Dr. Hammond and Dr. Pallen.
J.M. Friedman, MD, PhD, FAAP, FABMG, FCCMG, FRCPC
Acting Executive Director, Child & Family Research Institute
Acting Associate Dean (Research), Faculty of Medicine, and
Professor of Medical Genetics, University of British Columbia